Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of January 2025
The US FDA has approved a total of 3 new drug including 2 new molecular entities and 1 biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was Daiichi Sankyo &…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of December 2024
The US FDA has approved a total of 10 new drugs including 4 new molecular entities and 6 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was BMS’ Opdivo Qvantig…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of November 2024
The US FDA has approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was Jazz Pharmaceuticals’ Ziihera…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of October 2024
The US FDA has approved a total of 4 new drugs including 2 new molecular entities and 2 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Pfizer’s Hympavzi for…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024
The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of May 2024
The US FDA approved a total of 3 new drugs including 2 new molecular entities and 1 biologic leading to treatments for patients and advances in the healthcare industry
The major highlighted drug was Amgen’s Imdelltra for the treatment…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of April 2024
The US FDA approved a total of 12 new drugs including 11 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was X4 Pharmaceuticals’ Xolremdi for…

